Fig. 2From: ALK-TPM3 rearrangement in adult renal cell carcinoma: a case report and literature reviewNGS assay detected the fusion of ALK (donor end: chr2: 29447792) and TPM3 (acceptor start: chr1: 154140265) in the tumor visualized in the Integrative Genomics Viewer (IGV, www.broadinstitute.org/igv, human reference genome hg19). The fusion gene showedBack to article page